Dashboard
Manage Tickers

GOSS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

gossamer-bio-q3-eps-021-misses-018-estimate-sales-13294m
Gossamer Bio Q3 EPS $(0.21) Misses $(0.18)...
11/05/2025 21:31:41

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18...

gossamer-bio-enters-into-option-agreement-to-acquire-respira-therapeutics-and-its-lead-candidate-rt234-for-pulmonary-hypertension-gossamer-to-issue-25m-shares-in-connection-with-signing-and-shareholders-will-be-eligible-for-milestones
Gossamer Bio Enters into Option Agreement ...
09/25/2025 11:32:33

gossamer-bio-to-present-at-european-respiratory-society-ers-congress-2025-sept-28-and-30
Gossamer Bio To Present At European Respir...
09/22/2025 11:37:18

cantor-fitzgerald-reiterates-overweight-on-gossamer-bioto-overweight
Cantor Fitzgerald Reiterates Overweight on...
09/11/2025 12:32:05

Cantor Fitzgerald analyst Olivia Brayer reiterates Gossamer Bio (NASDAQ:GOSS) from Overweight to Overweight.

this-saia-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday
This Saia Analyst Turns Bullish; Here Are ...
09/10/2025 11:50:01

ubs-upgrades-gossamer-bio-to-buy-raises-price-target-to-9
UBS Upgrades Gossamer Bio to Buy, Raises P...
09/10/2025 10:44:11

UBS analyst Eliana Merle upgrades Gossamer Bio (NASDAQ:GOSS) from Neutral to Buy and raises the price target from $1.25 to $9.

wedbush-maintains-outperform-on-gossamer-bio-raises-price-target-to-5
Wedbush Maintains Outperform on Gossamer B...
08/06/2025 15:59:14

Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $4 to $5.

gossamer-bio-q2-eps-017-beats-018-estimate-sales-1149m-beat-434m-estimate
Gossamer Bio Q2 EPS $(0.17) Beats $(0.18) ...
08/05/2025 20:24:43

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) ...

ultragenyx-pharmaceutical-apple-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Ultragenyx Pharmaceutical, Apple And Other...
07/14/2025 12:14:56

scotiabank-initiates-coverage-on-gossamer-bio-with-sector-outperform-rating-announces-price-target-of-11
Scotiabank Initiates Coverage On Gossamer ...
07/14/2025 11:53:08

Scotiabank analyst Greg Harrison initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Sector Outperform rating and announ...

gossamer-bio-completes-enrollment-in-phase-3-prosera-trial-evaluating-seralutinib-for-pulmonary-arterial-hypertension
Gossamer Bio Completes Enrollment In Phase...
06/16/2025 11:36:20

gossamer-bio-completes-enrollment-in-registrational-phase-3-prosera-study-for-treatment-of-pulmonary-arterial-hypertension
Gossamer Bio Completes Enrollment In Regis...
06/16/2025 11:33:53

goldman-sachs-maintains-buy-on-gossamer-bio-raises-price-target-to-8
Goldman Sachs Maintains Buy on Gossamer Bi...
05/16/2025 16:49:55

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $7 to $8.

wedbush-reiterates-outperform-on-gossamer-bio-maintains-4-price-target
Wedbush Reiterates Outperform on Gossamer ...
05/16/2025 14:02:57

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.

gossamer-bio-q1-eps-016-beats-018-estimate-sales-989m-beat-407m-estimate
Gossamer Bio Q1 EPS $(0.16) Beats $(0.18) ...
05/15/2025 20:03:05

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) ...

Core News & Articles
Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

exploring-gossamer-bios-earnings-expectations
Exploring Gossamer Bio's Earnings Expectat...
05/14/2025 20:07:43

gossamer-bio-to-present-preclinical-data-at-american-thoracic-society-2025-international-conference
Gossamer Bio To Present Preclinical Data A...
05/07/2025 20:07:00

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization o...

goldman-sachs-maintains-buy-on-gossamer-bio-lowers-price-target-to-7
Goldman Sachs Maintains Buy on Gossamer Bi...
04/17/2025 17:38:17

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $8 to $7.

hc-wainwright--co-reiterates-buy-on-gossamer-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Goss...
03/18/2025 10:37:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price ta...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION